Apogee Therapeutics, Inc. (APGE)
USD 44.69
(-7.07%)
USD 44.69
(-7.07%)
| Breakdown | 2023 | 2022 |
|---|---|---|
| Operating Cash Flow | -74.76 Million | -16.42 Million |
| Net Income | -83.98 Million | -39.78 Million |
| Depreciation & Amortization | - | - |
| Deferred income taxes | - | - |
| Stock-based compensation | 6.1 Million | 2.14 Million |
| Change in working capital | 6.1 Million | 9.81 Million |
| Other non-cash items | -2.98 Million | 11.4 Million |
| Investing Cash Flow | -273.91 Million | - |
| Investments in PPE | -167 Thousand | - |
| Acquisitions | 273.74 Thousand | - |
| Investment purchases | -303.74 Million | - |
| Sales/Maturities of investments | 30 Million | - |
| Other Investing Activities | -273.74 Thousand | - |
| Financing Cash Flow | 315.39 Million | 183.61 Thousand |
| Debt repayment | - | - |
| Dividends payments | - | - |
| Common Stock Repurchased | - | - |
| Common Stock Issuance | 315.39 Million | 168.31 Million |
| Other Financing Activities | 315.39 Thousand | 183.61 Thousand |
| Accounts receivables | - | - |
| Accounts payables | 1.61 Million | 418 Thousand |
| Inventory | - | - |
| Other working capital | 4.49 Million | 9.39 Million |
| Cash at beginning of period | 151.89 Million | 168.13 Million |
| Cash at end of period | 118.31 Million | 151.89 Million |
| Capital Expenditure | -167 Thousand | - |
| Effect of forex changes on cash | -294 Thousand | - |
| Net cash flow / Change in cash | -33.57 Million | -16.24 Million |
| Free Cash Flow | -74.92 Million | -16.42 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -33.81 Million | -32.09 Million | -83.98 Million | -31.73 Million | -20.84 Million | -18.88 Million |
| Depreciation & Amortization | 36 Thousand | 29 Thousand | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 5.69 Million | 4.18 Million | 6.1 Million | 2.21 Million | 1.5 Million | 1.11 Million |
| Change in working capital | 1.54 Million | -1.31 Million | 6.1 Million | 2.52 Million | -313 Thousand | 3.2 Million |
| Other non-cash items | 1.78 Million | -359 Thousand | -2.98 Million | -2.75 Million | -232 Thousand | 9862.00 |
| Investing Cash Flow | -148.7 Million | -51.74 Million | -273.91 Million | -273.91 Million | -234.21 Million | - |
| Investments in PPE | -51 Thousand | -351 Thousand | -167 Thousand | -167 Thousand | - | - |
| Acquisitions | - | - | 273.74 Thousand | - | - | - |
| Investment purchases | -226.96 Million | -125.89 Million | -303.74 Million | -69.52 Million | -234.21 Million | - |
| Sales/Maturities of investments | 78.31 Million | 74.5 Million | 30 Million | 30 Million | - | - |
| Other Investing Activities | -148.65 Thousand | -51.39 Thousand | -273.74 Thousand | -234.21 Million | 234.21 Million | - |
| Financing Cash Flow | -150 Thousand | 450.52 Million | 315.39 Million | -213 Thousand | 317.29 Million | -1.69 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -213.00 | - | - |
| Common Stock Issuance | -150 Thousand | 450.52 Million | 315.39 Million | -213 Thousand | 315.6 Million | - |
| Other Financing Activities | -150.00 | 450.52 Thousand | 315.39 Thousand | 315.39 Million | 1.69 Million | -1694.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.22 Million | 2.15 Million | 1.61 Million | 1.03 Million | -9.76 Million | 9.86 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 317 Thousand | -3.47 Million | 4.49 Million | 1.48 Million | 9.44 Million | -6.66 Million |
| Cash at beginning of period | 485.45 Million | 118.31 Million | 151.89 Million | 188.26 Million | 125.06 Million | 141.33 Million |
| Cash at end of period | 307.29 Million | 485.45 Million | 118.31 Million | 118.31 Million | 188.26 Million | 125.06 Million |
| Capital Expenditure | -51 Thousand | -351 Thousand | -167 Thousand | -167 Thousand | - | - |
| Effect of forex changes on cash | - | - | -294 Thousand | 233.92 Million | - | - |
| Net cash flow / Change in cash | -178.15 Million | 367.14 Million | -33.57 Million | -69.95 Million | 63.2 Million | -16.26 Million |
| Free Cash Flow | -29.35 Million | -31.98 Million | -74.92 Million | -29.92 Million | -19.88 Million | -14.57 Million |
ADOC
0RGB
FIH-U
6678
BNOX
SUYOG